Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment

Journal of the Neurological Sciences

Volumn 284, Issue 1-2, 2009, Pages 77-80

  Xu, Gelin ^a   Zhou, Zhiming ^a   Zhu, Wusheng ^a   Fan, Xiaobing ^a   Liu, Xinfeng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

C reactive protein; Cognition; Dementia; Mild cognitive impairment; Prognosis; Vascular dementia

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CHINESE; COGNITION; CORRELATION ANALYSIS; DEMENTIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

AGED; ALCOHOL DRINKING; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; COGNITION DISORDERS; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK; SMOKING;

EID: 67849126665     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.04.018     Document Type: Article

References (21)

1. Kuo H.K., Yen C.J., Chang C.H., Kuo C.K., Chen J.H., and Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 4 6 (Jun 2005) 371-380
2. Nakase T., Yamazaki T., Ogura N., Suzuki A., and Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci. 271 1-2 (Aug 15 2008) 104-109
3. Hage F.G., and Szalai A.J. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 50 12 (Sep 18 2007) 1115-1122
4. Duong T., Nikolaeva M., and Acton P.J. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 749 1 (Feb 21 1997) 152-156
5. Locascio J.J., Fukumoto H., Yap L., Bottiglieri T., Growdon J.H., Hyman B.T., et al. Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol. 65 6 (Jun 2008) 776-785
6. Gunstad J., Bausserman L., Paul R.H., Tate D.F., Hoth K., Poppas A., et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci. 13 5 (Jun 2006) 540-546
7. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., et al. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet 367 9518 (Apr 15 2006) 1262-1270
8. Crum R.M., Anthony J.C., Bassett S.S., and Folstein M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269 18 (May 12 1993) 2386-2391
9. Xu G., Meyer J.S., Huang Y., Du F., Chowdhury M., and Quach M. Adapting mini-mental state examination for dementia screening among illiterate or minimally educated elderly Chinese. Int J Geriatr Psychiatry 18 7 (Jul 2003) 609-616
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (Feb 1960) 56-62
11. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (Jul 1984) 939-944
13. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 2 (Feb 1993) 250-260
14. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273 16 (Apr 26 1995) 1274-1278
15. Petersen R.C., and Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 62 7 (Jul 2005) 1160-1163
16. Boyle P.A., Wilson R.S., Aggarwal N.T., Tang Y., and Bennett D.A. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology 67 3 (Aug 8 2006) 441-445
17. Zacho J., Tybjaerg-Hansen A., Jensen J.S., Grande P., Sillesen H., and Nordestgaard B.G. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 359 18 (Oct 30 2008) 1897-1908
18. Fornage M., Chiang Y.A., O Meara E.S., Psaty B.M., Reiner A.P., Siscovick D.S., et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study. Stroke 39 7 (Jul 2008) 1952-1959
19. Hoshi T., Kitagawa K., Yamagami H., Furukado S., Hougaku H., and Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36 4 (Apr 2005) 768-772
20. Ravaglia G., Forti P., Maioli F., Brunetti N., Martelli M., Servadei L., et al. Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci. 60 8 (Aug 2005) 1017-1021
21. Yaffe K., Lindquist K., Penninx B.W., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80